T1 mapping performance and measurement repeatability: results from the multi-national T1 mapping standardization phantom program (T1MES)
Gabriella Captur, Abhiyan Bhandari, Rüdiger Brühl, Bernd Ittermann, Kathryn E. Keenan, Yang Ye, Richard J. Eames, Giulia Benedetti, Camilla Torlasco, Lewis Ricketts, Redha Boubertakh, Nasri Fatih, John P. Greenwood, Leonie E. Paulis, Chris Lawton, Chiara Bucciarelli‐Ducci, Hildo J. Lamb, Richard P. Steeds, Steve Leung, Colin Berry, Sinitsyn Valentin, Andrew Flett, Charlotte de Lange, Francesco De Cobelli, Magalie Viallon, Pierre Croisille, David Higgins, Andreas Greiser, Wenjie Pang, Christian Hamilton‐Craig, W. Strugnell, Tom Dresselaers, Andrea Barison, Dana Dawson, Andrew J. Taylor, François‐Pierre Mongeon, Sven Plein, Daniel Messroghli, Mouaz H. Al‐Mallah, Stuart M. Grieve, Massimo Lombardi, Jihye Jang, Michael Salerno, Nish Chaturvedi, Peter Kellman, David A. Bluemke, Reza Nezafat, Peter Gatehouse, James Moon
Abstract
The T 1 Mapping and Extracellular volume (ECV) Standardization (T1MES) program explored T 1 mapping quality assurance using a purpose-developed phantom with Food and Drug Administration (FDA) and Conformit Europenne (CE) regulatory clearance. We report T 1 measurement repeatability across centers describing sequence, magnet, and vendor performance.